Home › Opioid Overdose › NCT06565416
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial: Implementation of Screening and Brief Intervention
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Willing and able to provide informed consent * have English comprehension and proficiency * receiving services at one of our participating study sites * report current chronic pain and/or opioid misuse/opioid use disorder * self-identify as American Indian/Alaska Native Exclusion Criteria: * if they have a psychiatric, cognitive, or medical condition that interferes with the consenting process
About the study
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
What is being tested
- Implementation Strategies (behavioral)
Sponsor: University of New Mexico · Participants: 225 · Started: Jun 1, 2023
Contact the study team
- Kamilla L Venner, PhD · Phone: 5059252300
Official record on ClinicalTrials.gov — NCT06565416
Locations in the U.S.
| California | Clinic Site A (blinded pending tribal approval), Arcata |
| Minnesota | Clinic Site C (blinded pending tribal approval), Minneapolis (Not yet recruiting) |
| Washington | Clinic Site B (blinded pending tribal approval), Toppenish (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.